Literature DB >> 4079452

Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines.

L Danel, M Menouni, J H Cohen, J P Magaud, G Lenoir, J P Revillard, S Saez.   

Abstract

Estrogen receptors (ER) and androgen receptors (AR) were determined in a series of 23 leukemia or lymphoma cell lines including 8 T-cell lines, 12 B-cell lines, and 3 non lymphoid cell lines. The phenotypic characterization of these cells by currently available immunological markers provides an estimate of their stage of differentiation. The result indicate that none of the investigated cell lines bear simultaneously ER and AR. Four were found to bear ER: U266, RPMI 8226, HL60, IARC/310/LT2, and four to express AR: RAJI, IARC/301/LTI, U937, REH6. The presence of cytosolic receptors was always associated with that of nuclear receptors. The expression of either ER or AR is restricted to discrete maturation stages of different haemopoietic cell lineages. Thus AR were found among the most immature lines of the T, B or monocytic lineage but they could be detected neither in the promyelocytic line HL60, nor in the pluripotential K562. The present results are in keeping with the demonstration of AR in some leukaemic blasts or in non Hodgkin's lymphomas. In contrast with AR, ER are present in two myeloma cell lines, in the promyelocytic cell line, HL60 and in a T-cell line bearing the phenotype of mature suppressor/cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4079452     DOI: 10.1016/0145-2126(85)90125-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  18 in total

1.  Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.

Authors:  F Cerrato; M E Fernández-Suárez; R Alonso; M Alonso; C Vázquez; O Pastor; P Mata; M A Lasunción; D Gómez-Coronado
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

2.  Age and stage dependency of estrogen receptor expression by lymphocyte precursors.

Authors:  H Igarashi; T Kouro; T Yokota; P C Comp; P W Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 3.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

4.  Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development.

Authors:  N J Olsen; X Gu; W J Kovacs
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.

Authors:  H Offner; K Adlard; A Zamora; A A Vandenbark
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Effects of testosterone in the treatment of immune-mediated sensorineural hearing loss.

Authors:  Sang W Yeo; Ki-Hong Chang; Shi-Nae Park; Byung-Do Suh
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-28       Impact factor: 2.503

7.  Covalent modification of proteins by ligands of steroid hormone receptors.

Authors:  N Takahashi; T R Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  17Alpha-estradiol arrests cell cycle progression at G2/M and induces apoptotic cell death in human acute leukemia Jurkat T cells.

Authors:  Do Youn Jun; Hae Sun Park; Jun Seok Kim; Jong Sik Kim; Wan Park; Bang Ho Song; Hee-Sook Kim; Dennis Taub; Young Ho Kim
Journal:  Toxicol Appl Pharmacol       Date:  2008-06-04       Impact factor: 4.219

9.  17Beta-estradiol increases Leishmania mexicana killing in macrophages from DBA/2 mice by enhancing production of nitric oxide but not pro-inflammatory cytokines.

Authors:  C M Lezama-Dávila; A P Isaac-Márquez; J Barbi; S Oghumu; A R Satoskar
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

10.  Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

Authors:  Ho Sung Park; Jun Sang Bae; Sang Jae Noh; Kyung Min Kim; Ho Lee; Woo Sung Moon; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Kyu Yun Jang
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.